Tenax Therapeutics (TENX) Interest & Investment Income (2022 - 2026)
Tenax Therapeutics (TENX) posted quarterly Interest & Investment Income of $981000.0 for Q2 2026, up 2.83% year-over-year from $954000.0 in Q2 2025, and up 13.94% on a QoQ basis from $861000.0 in Q1 2026.
Tenax Therapeutics (TENX) Interest & Investment Income (2022 - 2026) Analysis & Trends
Tenax Therapeutics has reported Interest & Investment Income for 5 years, with the latest figure at $981000.0 in Q2 2026.
- Interest & Investment Income for Q2 2026 came in at $981000.0, up 2.83% year-over-year; the trailing twelve-month figure through Jun 2026 was $3.8 million (up 5.62% YoY), and the FY2025 annual result was $3.8 million, up 99.53% from the prior year.
- Interest & Investment Income advanced to $981000.0 in Q2 2026, from $861000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.0 million in Q4 2024 and troughed at -$150741.0 in Q3 2023.
- A 5-year average of $601075.6 and a median of $855938.5 in 2023 frame the typical range for Interest & Investment Income.
- The widest annual swing landed in 2023, when Interest & Investment Income jumped 221898.41%; it then fell 25.64% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at $63.0 in 2022, then soared by 1350498.41% to $850877.0 in 2023, then advanced by 20.7% to $1.0 million in 2024, then dropped by 10.61% to $918000.0 in 2025, then climbed by 6.86% to $981000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $981000.0 in Q2 2026, $861000.0 in Q1 2026, and $918000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - | 981,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 981,000.00 |
| Mar 31, 2026 | 861,000.00 |
| Dec 31, 2025 | 918,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 954,000.00 |
| Mar 31, 2025 | 930,000.00 |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 665,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Mar 31, 2024 | 118,000.00 |
| Dec 31, 2023 | 850,877.00 |
| Sep 30, 2023 | -150,741.00 |
| Jun 30, 2023 | 139,859.00 |
| Jun 30, 2022 | 63.00 |